These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities]. Ergünay K, Misirlioğlu M, Firat P, Tuncer ZS, Tuncer S, Yildiz I, Ustaçelebi S. Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425 [Abstract] [Full Text] [Related]
4. Quantitative analysis of human papillomavirus type 16 in cervical neoplasm: a study in Chinese population. Lo KW, Yeung SW, Cheung TH, Siu NS, Kahn T, Wong YF. J Clin Virol; 2005 Sep; 34(1):76-80. PubMed ID: 16002332 [Abstract] [Full Text] [Related]
5. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. Coutlée F, Trottier H, Gagnon S, Koushik A, Richardson H, Roger M, Ferenczy AS, Franco EL. J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216 [Abstract] [Full Text] [Related]
6. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Ekalaksananan T, Pientong C, Sriamporn S, Kongyingyoes B, Pengsa P, Kleebkaow P, Kritpetcharat O, Parkin DM. Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930 [Abstract] [Full Text] [Related]
7. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C. Clin Infect Dis; 2005 Feb 01; 40(3):451-7. PubMed ID: 15668870 [Abstract] [Full Text] [Related]
8. [Acceptable quality cervical cytology taking: comparison of Cervex-brush and Cervex-mex methods]. Ojeda Ortiz J, Muñoz Molina R, Pardo López M, Guevara Cruz M, Hernández Quijano T, Valencia Elizondo C, Hernández Valencia M. Ginecol Obstet Mex; 2008 Jul 01; 76(7):381-5. PubMed ID: 18798438 [Abstract] [Full Text] [Related]
9. The optimal technique for obtaining a Papanicolaou smear with the Cervex-Brush. Ferris DG, Berrey MM, Ellis KE, Petry LJ, Voxnaes J, Beatie RT. J Fam Pract; 1992 Mar 01; 34(3):276-80. PubMed ID: 1541953 [Abstract] [Full Text] [Related]
11. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs]. Ardiç N, Oztürk O, Ergünay K, Sezer O. Mikrobiyol Bul; 2009 Jul 01; 43(3):463-9. PubMed ID: 19795622 [Abstract] [Full Text] [Related]
12. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry. Narimatsu R, Patterson BK. Am J Clin Pathol; 2005 May 01; 123(5):716-23. PubMed ID: 15981811 [Abstract] [Full Text] [Related]
13. Real-time Taqman PCR targeting 14 human papilloma virus types. Lindh M, Görander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W. J Clin Virol; 2007 Dec 01; 40(4):321-4. PubMed ID: 17981499 [Abstract] [Full Text] [Related]
14. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)]. Sotlar K, Diemer D, Stubner A, Menton S, Menton M, Dietz K, Wallwiener D, Bültmann B. Verh Dtsch Ges Pathol; 2005 Dec 01; 89():195-200. PubMed ID: 18035691 [Abstract] [Full Text] [Related]
15. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia. Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P. J Clin Virol; 2012 May 01; 54(1):61-5. PubMed ID: 22326759 [Abstract] [Full Text] [Related]
16. Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR. Marks M, Gupta SB, Liaw KL, Kim E, Tadesse A, Coutlee F, Sriplienchan S, Celentano DD, Gravitt PE. J Virol Methods; 2009 Mar 01; 156(1-2):152-6. PubMed ID: 19022296 [Abstract] [Full Text] [Related]
17. Significance of atypical repair in liquid-based gynecologic cytology: a follow-up study with molecular analysis for human papillomavirus. Ng WK, Li AS, Cheung LK. Cancer; 2003 Jun 25; 99(3):141-8. PubMed ID: 12811854 [Abstract] [Full Text] [Related]
18. Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears. Salimović-Bešić I, Tomić-Čiča A, Smailji A, Hukić M. J Virol Methods; 2013 Dec 25; 194(1-2):222-8. PubMed ID: 24036071 [Abstract] [Full Text] [Related]
19. [Association between human papillomavirus (HPV) type 16 infection and E6/E7 gene variant and the cervical lesions in Beijing]. Yang YJ, Zhao J, Liao QP. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar 25; 21(1):32-4. PubMed ID: 17429529 [Abstract] [Full Text] [Related]
20. Molecular diagnosis of human papillomavirus: comparison between cervical and vaginal sampling. Finan RR, Irani-Hakime N, Tamim H, Almawi WY. Infect Dis Obstet Gynecol; 2001 Mar 25; 9(2):119-22. PubMed ID: 11495553 [Abstract] [Full Text] [Related] Page: [Next] [New Search]